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Prospective studies have shown that chronic low-grade inflammation may contribute to the
pathogenesis of the most common chronic diseases and in particular CVD. Obesity has
repeatedly been associated with moderately raised levels of inflammation, and this observation
has led to the view that obesity is characterised by a state of chronic low-grade inflammation.
There is now great interest in elucidating how physical activity and exercise modulate
inflammation. This review summarises the current research addressing the influence of physical
activity and exercise in mitigating the risks of obesity and diseases such as type-II diabetes and
CVD, through its action on the low-grade inflammatory state. Most research on this topic
hypothesised that the association between physical activity and inflammatory markers is
independent of fatness, but very few studies have proven this. Given that physical activity and
obesity are often inversely related, it is not clear as to whether the anti-inflammatory health
benefits of a physically active lifestyle are due to exercise per se or result from favourable
changes in the body composition.
Physical activity: Exercise: Low-grade inflammation: Obesity
Low-grade inflammation
Inflammation is a key function in the process by which the
body responds to an injury or an infection, and the acute
phase of inflammation normally leads to recovery from
infection to healing, and a return to normal values within a
few days. However, if the response is not properly phased,
the process can develop into a chronic low-grade inflam-
matory state which may trigger different diseases under
pathological conditions(1,2). Prospective studies in adults
have shown that chronic low-grade inflammation may
contribute to the pathogenesis of diseases such as athero-
sclerosis(3,4), type I- and type-II diabetes(1,2), cancer(5),
several types of neurodegenerative disorders(6) and auto-
immune diseases(7).
Several parameters of the inflammatory reaction can be
measured in plasma. The inflammatory markers that have
been shown to be associated with obesity or the metabolic
syndrome include acute phase proteins, pro-inflammatory
cytokines, adhesion molecules and adipokines (proteins
secreted by adipose tissue). C-reactive protein (CRP) con-
centrations are easily, accurately and fairly inexpensively
measured in blood. It is an acute phase reactant and a very
sensitive marker of inflammation. High-CRP levels have
no specificity in differentiating disease entities from one
another, but despite its lack of specificity, CRP has now
emerged as one of the most powerful predictors of cardio-
vascular risk(4,8,9). In a direct comparison of a panel of
inflammatory and lipid markers in their ability to predict
cardiovascular events in adults, CRP surpassed other classi-
cal risk markers, including LDL-cholesterol(10,11). The
American Heart Association and the Centres for Disease
Control and Prevention in the USA issued a joint statement
confirming that CRP is the best and most clinically useful
Abbreviation: CRP, C-reactive protein.
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of the markers of inflammation currently available, with
the following cut-off points for assessing CVD risk: low
risk (CRP<1.0 mg/l), average risk (1.0–3.0 mg/l) and high
risk (>3.0 mg/l)(8). Most studies use CRP as the only
marker of inflammation, however, choosing a wider spec-
trum of inflammatory markers can give us a better picture
of the specific mechanisms involved. Other commonly
used acute-phase reactants include complement factors
C3 and C4, serum amyloid A and ceruloplasmin. Pro-
inflammatory cytokines, such as IL-6, IL-1b and TNFa,
are often included in the panel of inflammatory markers
and have been associated with obesity and components of
the metabolic syndrome. The endothelial expression of
vascular adhesion molecules VCAM-1 and intracellular
adhesion molecule ICAM-1 and E-selectin are used as
markers of the filtration of inflammatory cells in the
arterial wall. Of the adipokines, the most studied is adipo-
nectin(1,12).
Obesity-induced chronic low-grade inflammation
Obesity has repeatedly been associated with moderately
raised levels of inflammation, and this observation has led
to the view that obesity is characterised by a state of
chronic low-grade inflammation(13). Adipose tissue is now
widely recognised as having endocrine functions(13).
Adipokines are locally produced in the adipose tissue seem
to increase the hepatic synthesis of acute phase inflamma-
tory proteins (e.g. CRP, complement factors and serum
amyloid A). The continued identification of bioactive pro-
teins secreted by adipokines supports the theory that an
excess of adipocity plays a central role in the metabolic
syndrome and in insulin resistance(1,2,12).
In the metabolic syndrome, obesity is the main deter-
minant of inflammation, and the relative implication of
each component may be difficult to disaggregate when
they cluster together in a metabolic disorder.
Insulin: an anti-inflammatory hormone?
Recent observations in in vitro studies have proposed a
pro-inflammatory effect of glucose and an anti-inflamma-
tory action of insulin(1,2,12). These observations have led to
a working hypothesis explaining how the pro-inflammatory
state that accompanies the metabolic syndrome associates
with both insulin resistance and endothelial dysfunction,
via the connection between inflammation and metabolic
processes. This hypothesis would also explain why insulin-
resistant states (like obesity and type-II diabetes) are
associated with oxidative stress, inflammation and athero-
sclerosis.
Physical activity counteracting obesity-induced
low-grade inflammation
Body fat seems to be the main determinant of inflamma-
tion. However, physical activity is a major modifiable risk
factor of obesity and therefore offers a potential thera-
peutic approach to modulate low-grade inflammation.
The health benefits of a physically active lifestyle are
well recognised. Physical inactivity and obesity are also
increasingly recognised as modifiable behavioural risk
factors for a wide range of chronic diseases, and in par-
ticular for CVD(14). It could therefore be reasonable to
hypothesise that health benefits attributed to physical
activity may be mediated by reducing or preventing
inflammation.
Physical fitness, physical exercise and physical activity
are used as interchangeable concepts in most reviews on
this topic, but it is important to point out the differences to
highlight the potential differences in outcomes. Physical
activity is any body movement that increases energy
expenditure(15). Self-reported data of physical activity is
easy and feasible to ask in a questionnaire or interview in
large populations, but is a measurement subject to recall
and reporting biases. Exercise is planned, structured and
repetitive physical activity, while physical fitness is the
capacity to perform physical activity, and makes reference
to a full range of physiological and psychological qualities.
Physical fitness has been also defined as ‘a set of attributes
that people have or achieve that relates to the ability to
perform physical activity’(15). To eliminate reporting bias
that could be present in self-reported physical activity
measurement, several studies have examined the relation-
ship between cardiorespiratory fitness and inflammatory
markers.
VO2max attained during a graded maximal exercise to
voluntary exhaustion has long been considered by WHO as
the single best indicator of cardiorespiratory fitness(16).
Nevertheless, one should bear in mind that the measure-
ments are different and that different metabolic pathways
for any possible anti-inflammatory effect could be present,
and therefore clearly differentiate the methodologies used.
Excellent reviews of the evidence addressing the influ-
ence of physical activity and fitness on low-grade inflam-
mation from epidemiological studies as well as clinical
trials on the general adult population have been pub-
lished(17,18), also in athletes(19,20), and to a lesser extent in
children and adolescents(21). A wide range of inflammatory
markers have been measured and assessed against physical
activity; these include fibrinogen, cytokines, leucocytes,
although CRP is by far the most commonly used.
Acute v. regular exercise
IL-6 and other cytokines which are produced and released
by skeletal muscles have been suggested to be involved
in mediating the health-beneficial effects of exercise and
play important roles in the protection against diseases
associated with low-grade inflammation. The following
hypothesis is based on years of observation by Pedersen and
co-workers(22–24): plasma IL-6 increases in an exponential
fashion with exercise and is related to exercise intensity,
duration, the mass of muscle recruited and one’s endurance
capacity. Consequently, the contracting skeletal muscle is
a major source of circulating IL-6 in response to acute
exercise. During heavy exercise, such as a marathon, there
is up to a 60-fold increase in the IL-6 plasma levels(25)
with the duration of the event explaining more than 50%
of the variation(26). The mentioned plasma IL-6 increase
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supports the hypothesis that the post-exercise cytokine
production is related to skeletal muscle damage with an
acute inflammatory response(27).
Interestingly, IL-6 shows a markedly lower response to
acute exercise in trained subjects. The health benefits
of long-term regular exercise are ascribed to the anti-
inflammatory response elicited by an acute bout of ex-
ercise, which is partly mediated by muscle-derived IL-6.
Physiological concentrations of IL-6 stimulate the appear-
ance in the circulation of the anti-inflammatory cytokines
IL-1ra and IL-10, and inhibit the production of the pro-
inflammatory cytokine TNFa. The anti-inflammatory
effects of exercise may therefore offer protection against
TNF-induced insulin resistance. Moreover, IL-6 stimulates
lipolysis as well as fat oxidation. The increase of IL-6 at
the end of acute exercise is responsible for the increased
CRP levels during late recovery. In response to regular
physical activity, basal as well as post-exercise plasma
levels of IL-6 decreases by mechanisms that might include
increased glycogen content, improved anti-oxidative ca-
pacity and improved insulin sensitivity. The lower levels of
IL-6 in circulation will subsequently result in lower CRP
levels. When untrained, basal plasma IL-6 and CRP levels
are elevated via mechanisms that may involve impaired
insulin sensitivity and/or increased oxidative stress(22,23).
Few studies have prospectively examined the effect of
exercise training on low-grade inflammatory status, and the
data obtained from intervention studies are less consistent
when compared with cross-sectional population studies or
with clinical experiments. A lower number of subjects or a
good physical condition at the start of some intervention
studies may explain a part of this inconsistency. Never-
theless, two longitudinal studies in athletes show that reg-
ular training induces a reduction in the CRP level(28,29).
Physical activity-based lifestyle change appears to be
the most variable component of energy expenditure and
therefore has been the target of behavioural interventions
to modify body weight. However, combined dietary and
exercise interventions do not provide consistent evidence
that exercise per se and not weight loss is more important
for reducing inflammatory factors, and it is beyond this
summary and can be reviewed elsewhere(30).
Conflicting findings exist in clinical trials that have
involved exercise only. Several training interventions have
not produced changes in the basal IL-6 or CRP(31–34),
while significant reductions in inflammatory markers have
been observed following training without changes in BMI
or body fat in elderly participants(35,36). The biggest trial
with exercise training on inflammation was performed in
652 sedentary healthy, young and middle-aged, white and
black women and men in the HERITAGE Family Study
after a 20-week training intervention(37). There was no
control group to compare with, and every subject served as
his/her own control. A non-significant reduction was con-
sistent across all population groups and varied between 1.2
and 2.2 mg/l. Considering that the variation over time in
CRP in healthy individuals with stable lifestyles is small(8),
the reduction, although non-significant, could nevertheless
reflect the true effect of exercise training. Further stratifi-
cation according to basal CRP levels showed a reduction
by about 1.3 mg/l in subjects with initial CRP levels above
3.0 mg/l. This observation is potentially important from a
public health and clinical point of view by decreasing the
risk of CVD in individuals with high CRP. Thus, baseline
levels may be an important factor.
Elderly people and disease states
Elderly people have higher basal levels of inflammation
independent of disease status, and a considerable number
of studies have been carried out in this population to assess
the associations between physical activity and inflamma-
tory markers(38–43). Rather consistent inverse BMI inde-
pendent associations are found and the associations are
suggested to be dose-dependent; the more physically active
the person, the lower the inflammatory markers(24,44). Also,
subjects over 80 years show consistent inverse associations
between inflammation and physical activity(45). A mean
score of functional fitness was associated with IL-6, and
IL-1RA (but not CRP, TNFa, IL-10 or IL-1b) in a pro-
spective population-based study of 1020 participants aged
65 years and above(38,46). Muscle strength was also evalu-
ated in this study and low hand-grip strength was as-
sociated with high levels of CRP (P<0.001) and IL-6
(P<0.001)(46). A few more studies have shown a negative
association of CRP, IL-6 and TNFa with muscle
strength(41,47).
Exercise intervention in elderly people or patients with
CVD shows more consistent results of an anti-inflamma-
tory effect. After a 6-month individualised, supervised
exercise programme for 43 subjects at a high risk of IHD,
a trend towards reduced CRP levels (35%) was observed.
The subjects exercised for a mean of 2.5 (range, 0.3–7.4) h
per week(48). Another study has reported a decrease of
basal plasma IL-6 after aerobic training in patients with
coronary artery disease(49). A randomised trial of 39
patients with intermittent claudication demonstrated that
both serum CRP and amyloid-A levels were significantly
reduced after 3 and 6 months of supervised exercise com-
pared with controls(50). In a relatively large intervention
study of exercise training on cardiac rehabilitation patients,
the median CRP concentrations were significantly reduced
by 41% (mean change from 5.9 (SD 7.7) mg/l to 3.8
(SD 5.8) mg/l; median change from 3.4 to 2.0 mg/l) in 235
patients with coronary artery disease, while CRP con-
centration did not change in 42 subjects who did not
exercise(51). Again, the exercise training seemed to be
more effective in those with the highest CRP concentra-
tion, independent of changes in body weight or percentage
of body fat(51) indicating that baseline levels of low-grade
inflammation may be an important factor.
In disease states such as symptomatic CVD or in
patients with the metabolic syndrome, as well as in elderly
people, levels of inflammatory markers are generally
higher than in healthy young adults. Evidence points out
that higher basal low-grade inflammation may be a factor
in determining the relative contribution of fitness. Studies
in patients with diabetes(52) and metabolic syndrome(53,54)
have consistently demonstrated inverse associations
between fitness and inflammation independent of fatness.
In one study, the independent associations of fitness were
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in fact more prominent among metabolic syndrome
patients compared with healthy participants(53,54).
Middle-aged, younger adults and children
Several studies of large population cohorts, such as the
British Regional Heart Study(40), the ATTICA study(55),
the Third National Health and Nutrition Examination Sur-
vey(56,57), the men’s Health Professionals Follow-up
Study(58), the Nurses’ Health Study II(58) and the Women’s
Health Study(59), provide evidence for an inverse, inde-
pendent dose–response relationship between plasma CRP
concentration and level of physical activity in both men
and women, but the consistency is less than in elderly
subjects, or in disease states.
On the contrary, the associations found between self-
reported physical activity, and soluble receptor of TNF-R1
and TNF-R2, serum IL-6 and CRP in a study including
healthy men from The Men’s Health Professionals Follow-
up Study and healthy women from the Nurses’ Health
Study II(58) were no longer significant when adjusting for
BMI and leptin, suggesting that inflammation does not
directly account for the beneficial effects of physical
activity. The effects in healthy men and women of BMI,
CRP and physical activity were measured longitudinally
over 1 year and retrospectively for physical activity the
previous year, concluding that BMI, but not previous year
or current physical activity, predicts CRP(60). A univariate
analysis of CRP levels in 2120 Finns showed that CRP was
associated with obesity indices and physical activity
among both sexes(61). In multivariate correlates, however,
the determinants of CRP levels include obesity and smoking
in men and obesity, oral contraceptives use and physical
activity in women. The study showed that about one in
three healthy women who used oral contraceptives had
CRP concentration exceeding 3 mg/l, which should be
taken into account when studying younger females. In a
longitudinal study(60) of healthy men and women, BMI, but
not current- or previous-year physical activity, was signifi-
cantly related to CRP. Similarly, a cross-sectional study(62)
in men found no relationship between leisure time, physical
activity and CRP, fibrinogen and serum amyloid A, after
correction for BMI and current smoking status.
Cross-sectional studies in men from the Aerobics Center
Longitudinal Study have demonstrated that cardio-
respiratory fitness levels are inversely associated with CRP
values and also the prevalence of elevated CRP values(63).
Analyses with fibrinogen and leucocyte count showed
similar results(64). The competing effect of weight and fit-
ness (assessed by submaximal graded exercise treadmill
testing) on cardiorespiratory fitness levels was studied in
the NHANES (1999–2002) which included 2112 US adults
without previously diagnosed CVD(65). Both fitness and
BMI were independently associated with increased fasting
insulin and CRP. However, when patients with low,
moderate and high fitness were further stratified as normal,
overweight, or obese, weight remained significantly associ-
ated with CRP, but fitness did not.
Disease-free young population studies have assessed the
interaction between inflammatory markers (CRP, IL-6 and
TNFa), physical activity or cardiorespiratory fitness and
fatness(66–74). Organised leisure time exercise (assessed by
questionnaire) in children has shown negative correlations
with serum IL-6 concentrations, independent of adiposity
and fat localisation(68), and in 10-year-old children, a bor-
derline significant negative association was observed
between CRP and self-reported physical activity, indepen-
dent of ponderal index(66). US children and young adults
(aged 6 to 24 years) from the Columbia University Bio-
Markers Study showed an inverse correlation between
cardiovascular fitness level and CRP, but only in boys,
which remained after adjustment of confounders including
BMI(69). Only one study has used accelerometry (an
objective measure of total physical activity compared with
leisure time physical activity or exercise) instead of ques-
tionnaires as well as cardiovascular fitness(74). In this study
of 9-year-old Swedish children, total physical activity was
unrelated to CRP, fibrinogen, C3 or C4, but exercise was.
Nevertheless, once body fat was entered in the regression
models, no associations with cardiovascular fitness or
physical activity and either of the inflammatory markers
measured were observed(74). Similarly, no associations
were found between cardiorespiratory fitness or self-
reported physical activity and CRP in 12-year-old healthy
Welsh children(75).
CRP, C3 and ceruloplasmin (but not C4) were nega-
tively associated with muscle strength after controlling for
sex, age, pubertal status, weight, height, socioeconomic
status and cardiorespiratory fitness, but did not remain
when adjusting body fat. Nevertheless, when stratifying
according to overweight status, CRP (but not C3, C4 or
ceruloplasmin) was associated with muscle strength in
overweight adolescents (but not normal weights) after
controlling for potential confounders, including body fat
and fat-free mass(76).
Gender effects
It has been suggested that the role of fatness in relation to
fitness and inflammatory pathways may be especially
prominent in women(17). In three studies(38,42,69) an inverse
relationship between fitness and CRP was demonstrated for
males, but not females after adjusting for fatness. The
reason for this gender-related discrepancy is unclear, but
may be related to less physical activity in women. Never-
theless, there is a close link between sex steroids, sub-
clinical inflammation, insulin resistance and body fat
distribution in regularly menstruating women, and serum
concentrations of CRP significantly change during the
menstrual cycle(77). Furthermore, CRP levels are more
strongly related to insulin resistance and the individual
components of the metabolic syndrome in women than in
men(78).
Summary
Most research on this topic hypothesised that the associ-
ation between fitness and inflammatory factors is indepen-
dent of fatness. Given that physical activity and obesity
are often inversely related, it is not clear as to whether the
anti-inflammatory health benefits of a physically active
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lifestyle are due to exercise per se or result from favour-
able changes in body composition. Related anti-inflamma-
tory effects could be mediated by increased insulin
sensitivity and/or improved concentrations of HDL-chol-
esterol, reactive oxygen species or endothelial function,
which all demonstrate anti-inflammatory actions(79), and
are related to both body fat and exercise. A systematic
review by Hamer addresses whether fitness or fatness has
the greatest impact on inflammatory factors(17). The review
concluded that both fitness and fatness are associated with
systemic inflammatory status, although the relative con-
tributions of both may be dependent on age, disease status
and gender. For example, the association between adipos-
ity and low-grade systemic inflammation has been shown
to be considerably stronger in women than in men(80).
Most apparent is the comparison between consistency
in studies between elderly population and children or
adolescents, or obese v. lean subjects.
Although increasing physical activity may be an ef-
fective therapy for weight loss and may also emerge as a
promising treatment for reducing overall inflammation, the
magnitude of the effect to produce clinically meaningful
results in the general population requires further research.
Nevertheless, exercise is uniquely positioned to reduce
inflammation and even small non significant reductions in
CRP levels may contribute to clinical benefits by reducing
cardiovascular and metabolic risk.
Conclusions
Few studies have proven that the association between
physical activity and inflammatory markers is independent
of fatness. Given that physical activity and obesity are
often inversely related, it is not clear as to whether the
anti-inflammatory health benefits of a physically active
lifestyle are due to exercise per se or result from favour-
able changes in body composition. Nevertheless, we con-
sider that there is enough evidence to suggest that regular
physical activity induces favourable changes on the meta-
bolic profile including the inflammatory status, contribu-
ting as such to clinical benefits by reducing cardiovascular
and metabolic risk.
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